Pregnancy outcome after early exposure to nivolumab, a PD-1 checkpoint inhibitor for relapsed Hodgkin ’s lymphoma

.

Source: Clinical Toxicology - September 21, 2021 Category: Toxicology Authors: Janine R. Hutson Genevieve Eastabrook Facundo Garcia-Bournissen Source Type: research